These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29874189)

  • 1. Novel splice variants of the human kallikrein-related peptidases 11 (KLK11) and 12 (KLK12), unraveled by next-generation sequencing technology.
    Adamopoulos PG; Kontos CK; Scorilas A
    Biol Chem; 2018 Sep; 399(9):1065-1071. PubMed ID: 29874189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and molecular cloning of novel transcripts of the human kallikrein-related peptidase 10 (KLK10) gene using next-generation sequencing.
    Adamopoulos PG; Kontos CK; Scorilas A
    Biochem Biophys Res Commun; 2017 Jun; 487(4):776-781. PubMed ID: 28419837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing.
    Adamopoulos PG; Kontos CK; Scorilas A
    Sci Rep; 2017 Dec; 7(1):17299. PubMed ID: 29229980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology.
    Adamopoulos PG; Kontos CK; Scorilas A
    Genomics; 2019 Jul; 111(4):642-652. PubMed ID: 29614347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, Molecular Characterization and Alternative Splicing of Three Novel Members of the Canine Kallikrein (Klk)-related Peptidase Family.
    Angelopoulou K; Karagiannis GS
    Anticancer Res; 2015 May; 35(5):2715-23. PubMed ID: 25964550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3'RACE and high-throughput sequencing.
    Adamopoulos PG; Koukouzeli FΕ; Kontos CK; Scorilas A
    Gene; 2020 Jul; 749():144708. PubMed ID: 32334022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages.
    Komatsu N; Takata M; Otsuki N; Toyama T; Ohka R; Takehara K; Saijoh K
    J Invest Dermatol; 2003 Sep; 121(3):542-9. PubMed ID: 12925213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
    Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
    Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.
    Talieri M; Devetzi M; Scorilas A; Pappa E; Tsapralis N; Missitzis I; Ardavanis A
    Tumour Biol; 2012 Aug; 33(4):1075-84. PubMed ID: 22351561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer.
    Angelopoulou K; Prassas I; Yousef GM
    Gene; 2009 Oct; 446(2):68-74. PubMed ID: 19619623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.
    Yousef GM; Magklara A; Diamandis EP
    Genomics; 2000 Nov; 69(3):331-41. PubMed ID: 11056051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
    Planque C; Aïnciburu M; Heuzé-Vourc'h N; Régina S; de Monte M; Courty Y
    Biol Chem; 2006 Jun; 387(6):783-8. PubMed ID: 16800740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdependence of kallikrein-related peptidases in proteolytic networks.
    Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
    Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intron retention: a common splicing event within the human kallikrein gene family.
    Michael IP; Kurlender L; Memari N; Yousef GM; Du D; Grass L; Stephan C; Jung K; Diamandis EP
    Clin Chem; 2005 Mar; 51(3):506-15. PubMed ID: 15650036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer.
    Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM
    Tumour Biol; 2016 Jan; 37(1):437-46. PubMed ID: 26224476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms.
    Koumandou VL; Scorilas A
    PLoS One; 2013; 8(7):e68074. PubMed ID: 23874499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel alternative splice variants of the human protein arginine methyltransferase 1 (PRMT1) gene, discovered using next-generation sequencing.
    Adamopoulos PG; Mavrogiannis AV; Kontos CK; Scorilas A
    Gene; 2019 May; 699():135-144. PubMed ID: 30849541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and expression analysis of novel transcripts of the human SR-related CTD-associated factor 1 (SCAF1) gene in human cancer cells using Next-Generation Sequencing.
    Adamopoulos PG; Raptis GD; Kontos CK; Scorilas A
    Gene; 2018 Sep; 670():155-165. PubMed ID: 29787824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.
    Guillon-Munos A; Oikonomopoulou K; Michel N; Smith CR; Petit-Courty A; Canepa S; Reverdiau P; Heuzé-Vourc'h N; Diamandis EP; Courty Y
    J Biol Chem; 2011 Jul; 286(29):25505-18. PubMed ID: 21628462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
    Thomadaki H; Mavridis K; Talieri M; Scorilas A
    Thromb Haemost; 2009 Feb; 101(2):373-80. PubMed ID: 19190824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.